Daily Oral Linaclotide Significantly Improves Frequent Constipation in Pediatric Patients Through 12 Weeks
Findings from the pivotal phase 3 trial that which supported linaclotide's FDA approval show significant benefit in bowel movement and stool consistency.
United States San Diego American Society For Pediatric Gastroenterology Drug Administration Carlo Di Lorenzo North American Society
Source: hcplive.com